Implications of MicroRNAs in the Treatment of Gefitinib-Resistant Non-Small Cell Lung Cancer

Non-small cell lung cancer (NSCLC) represents about 85% of the reported cases of lung cancer. Acquired resistance to targeted therapy with epidermal growth factor receptor-tyrosine kinase inhibitors (EGFR-TKIs), such as gefitinib, is not uncommon. It is thus vital to explore novel strategies to rest...

Descripción completa

Detalles Bibliográficos
Autores principales: Sin, Thomas K., Wang, Fengfeng, Meng, Fei, Wong, S. C. Cesar, Cho, William C. S., Siu, Parco M., Chan, Lawrence W. C., Yung, Benjamin Y. M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2016
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4783968/
https://www.ncbi.nlm.nih.gov/pubmed/26891293
http://dx.doi.org/10.3390/ijms17020237

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4783968/
https://www.ncbi.nlm.nih.gov/pubmed/26891293
http://dx.doi.org/10.3390/ijms17020237

Ejemplares similares